Subependymomas

Subependymoma is a rare, typically slow‑growing neoplasm classified as World Health Organization grade I. It originates from cells in the subependymal zone lining the ventricular system of the brain. The tumors usually appear in adults between the fourth and sixth decades of life, with a slight male predominance, and are exceedingly uncommon in children. Histologically, subependymomas consist of clusters of uniform, bland nuclei surrounded by a delicate fibrillary matrix; they often contain perivascular pseudorosettes but lack significant pleomorphism or necrosis. Low mitotic activity and absence of microvascular proliferation distinguish them from higher‑grade gliomas.

Clinically, many subependymomas remain asymptomatic and are incidentally detected on imaging performed for unrelated reasons. When symptoms arise, they are usually related to mass effect or obstructive hydrocephalus and include headache, gait disturbance, or focal neurological deficits. Seizures and signs of increased intracranial pressure are less common.

Magnetic resonance imaging is the modality of choice. On T1‑weighted images the tumor is generally iso‑ or slightly hypointense relative to gray matter; on T2‑weighted and FLAIR sequences it is hyperintense, and enhancement after gadolinium is minimal or absent. CT may show a hypodense, nonenhancing mass with possible calcification. Preoperative diagnosis relies on imaging combined with patient history, but definitive classification comes from histopathologic examination following surgical sampling.

Treatment is usually gross total or subtotal resection, which offers excellent long‑term control and low recurrence rates. Close imaging surveillance is recommended; adjuvant radiotherapy is reserved for residual tumors that progress. The overall prognosis is favorable, with most patients remaining symptom‑free and alive beyond a decade after surgery.